Contact
Please use this form to send email to PR contact of this press release:
U.S. FDA Files New Drug Application Under Priority Review for Migalastat for Treatment of Fabry Disease
TO:
Please use this form to send email to PR contact of this press release:
U.S. FDA Files New Drug Application Under Priority Review for Migalastat for Treatment of Fabry Disease
TO: